Etodolac Nanogel as an Adjunct to Physiotherapy for Knee Osteoarthritis

Trial statusNot yet recruiting
Trial phasePhase 2
Trial typeInterventional
Biological sexAll
Age45-60
SponsorPharos University in Alexandria

About this trial

Brief Summary:

Knee osteoarthritis (OA) is a common, disabling condition affecting the weight-bearing knee joint, leading to pain, reduced function, and muscle weakness, particularly of the quadriceps. Strengthening exercises are recommended to improve joint stability, physical function, and slow disease progression. Etodolac, a selective NSAID approved for osteoarthritis, has proven analgesic and anti-inflammatory effects. This study investigates the adjunctive effect of a topical Etodolac-loaded solid lipid nanoparticle gel combined with traditional physiotherapy in patients with knee OA. Thirty patients with mild to moderate unilateral tibiofemoral OA will be randomized into two groups: traditional physiotherapy alone or physiotherapy plus Etodolac gel. Outcomes including pain, knee function, functional performance, quadriceps strength, and proprioception will be assessed at baseline and after four weeks. The study aims to determine whether adding topical Etodolac enhances the benefits of standard physiotherapy in managing knee OA.

Eligibility criteria

Qualifiers

Age between 45 and 60 years.

Disqualifiers

Severe or bilateral knee osteoarthritis (Kellgren-Lawrence grade IV).

Trial design

Treatments tested in this trial

  • Etodolac-Loaded Solid Lipid Nanoparticle Gel

Treatment groups

30 Participants
are divided into 2 treatment groups